Acute Coronary Syndrome

Updated: April 7, 2025

Mail Whatsapp PDF Image

Background

Acute coronary syndrome (ACS) refers to a range of conditions caused by a sudden reduction or blockage of blood flow to the heart muscle, often due to the rupture of a plaque in the coronary arteries. ACS is a medical emergency and includes three main types: unstable angina, non-ST segment elevation myocardial infarction (NSTEMI), and ST-segment elevation myocardial infarction (STEMI). Unstable angina involves a partial blockage and causes chest pain or discomfort, serving as a warning sign of a potential heart attack. NSTEMI is less severe, with partial or temporary blockage leading to some heart muscle damage. STEMI is the most severe, involving a complete blockage and causing significant heart muscle damage, requiring immediate medical attention.

Epidemiology

Acute coronary syndrome (ACS): Leading cause of morbidity and mortality worldwide, affecting millions annually.

Incidence: Varies by region, age, and other factors; common cardiovascular emergency.

Prevalence: Influenced by risk factors such as hypertension, diabetes, smoking, and obesity.

Gender differences: Historically more common in men, but the gender gap is narrowing; significant cause of death and morbidity in both genders.

Seasonal pattern: Increased incidence during winter; cold weather and other factors may contribute to this variation.

Anatomy

Pathophysiology

Acute coronary syndrome (ACS): Involves a reduction in blood flow to a segment of the heart muscle.

Primary cause: Typically, due to the rupture of a plaque within a coronary artery.

Thrombus formation: The rupture leads to the formation of a blood clot (thrombus).

Other causes: Can also be attributed to vasospasm, with or without underlying atherosclerotic conditions.

Initial effect: Reduced blood flow results in ischemia (insufficient blood supply).

Subsequent effect: Ischemia leads to infarction (tissue damage) of the affected heart region.

Etiology

Acute Coronary Syndrome (ACS): Manifestation of coronary heart disease.

Primary cause: Disruption of plaques within the coronary arteries.

Prevalent risk factors:
Smoking
Diabetes
High blood pressure
Elevated lipid levels
Sedentary lifestyle
Familial obesity
Poor dietary habits
Cocaine abuse: Can induce vasospasms, increasing risk.

Family history: Early myocardial infarction (before age 55) is a significant risk factor.

Genetics

Prognostic Factors

Clinical History

Acute coronary syndrome (ACS) often affects individuals with risk factors like coronary artery disease (CHD), smoking, hypertension, diabetes, hyperlipidemia, and a family history of heart disease. Patients may have a history of angina or heart attacks.

Symptoms include new or worsening chest pain (crushing, squeezing, or pressure-like), shortness of breath, nausea, vomiting, and sweating.

ACS typically has a sudden onset and can present with persistent or intermittent symptoms, including rest and exertional angina. The exact symptoms can vary among individuals.

Age group
Middle-Aged Adults (40-60 years):
This is a more common age range for ACS, as risk factors such as hypertension, high cholesterol, smoking, and diabetes tend to accumulate during this period.
Men typically have a higher incidence of ACS in this age group, although the gap is narrowing as cardiovascular risk factors in women rise.

Older Adults (Over 60 years):
ACS becomes much more common in this age group, with the risk increasing as people age due to the natural progression of coronary artery disease (CAD), which often goes undiagnosed for many years.

Physical Examination

Patients with ACS often exhibit general distress and diaphoresis. Heart sounds are usually normal, but in some cases, healthcare providers may detect additional sounds like gallops or murmurs. Lung examination typically reveals no abnormalities, though crackles may be heard in some cases, suggesting associated congestive heart failure. Bilateral leg swelling or edema may be present, which can be indicative of CHF. Evaluations of other body systems typically yield results within normal limits unless there are concurrent medical conditions. When abdominal tenderness is noted upon palpation, healthcare providers should consider the possibility of other conditions, such as pancreatitis or gastritis. The presence of unequal pulses should raise suspicion of aortic dissection, warranting further evaluation. If unilateral leg swelling is detected, a thorough work-up for pulmonary emboli is advisable.

Age group

Associated comorbidity

Hypertension (High Blood Pressure)
Diabetes Mellitus
Dyslipidemia (Abnormal Cholesterol Levels)
Peripheral Artery Disease (PAD)

Associated activity

Acuity of presentation

ST-Elevation Myocardial Infarction (STEMI):

Most acute: Sudden, severe chest pain, often crushing in nature, with rapid deterioration. Immediate intervention (e.g., PCI or thrombolysis) is critical to minimize heart damage.

Non-ST-Elevation Myocardial Infarction (NSTEMI):
Moderately acute: Chest pain, shortness of breath, and discomfort may be less intense but still severe. Requires urgent care with antiplatelet therapy and potential angiography.

Unstable Angina:
Less acute but still urgent: Chest pain at rest or with minimal exertion, with no significant muscle damage (no troponin elevation). Needs close monitoring and possible early revascularization.

Differential Diagnoses

Acute pericarditis
Aortic stenosis
Anxiety disorders
Asthma
Dilated cardiomyopathy
Esophagitis
Myocardial infarction

Laboratory Studies

Imaging Studies

Procedures

Histologic Findings

Staging

Treatment Paradigm

Immediate medical assessment and diagnosis:
Electrocardiography (ECG) and cardiac biomarker tests

Initial treatments:
Oxygen therapy
Pain relief with nitroglycerin and opioids
Administration of antiplatelet and anticoagulant medications

Revascularization procedures (Depending on type of ACS – STEMI or NSTEMI):
Primary percutaneous coronary intervention (PCI)
Thrombolytic therapy

Long-term management:
Beta-blockers
ACE inhibitors or ARBs
Statins
Lifestyle modifications
Cardiac rehabilitation

Psychological support:
Addressing the emotional impact of ACS
Ensuring comprehensive care and better patient outcomes

by Stage

by Modality

Chemotherapy

Radiation Therapy

Surgical Interventions

STEMI: Urgent revascularization is the goal. This can be achieved through primary percutaneous coronary intervention (PCI) or thrombolytic therapy. PCI is preferred if available within a timely window.

NSTEMI: An early invasive strategy, involving coronary angiography and PCI if indicated, is commonly employed.

Hormone Therapy

Immunotherapy

Hyperthermia

Photodynamic Therapy

Stem Cell Transplant

Targeted Therapy

Palliative Care

lifestyle-modifications-in-treating-acute-coronary-syndrome

Encourage patients to make lifestyle changes, such as quitting smoking, adopting a heart-healthy diet, losing weight if necessary, and managing underlying risk factors like hypertension and diabetes.

Effectiveness of Antiplatelet and Anticoagulant Therapy in treating Acute Coronary Syndrome

Cardiology
Aspirin is administered promptly to inhibit platelet aggregation. Additional antiplatelet agents like P2Y12 inhibitors (e.g., clopidogrel, ticagrelor, or prasugrel) are initiated. Anticoagulants such as heparin or enoxaparin are given to prevent further clot formation.

Use of Beta-Blockers in treating Acute Coronary Syndrome

Beta-blockers, like metoprolol, may be administered to reduce heart rate, blood pressure, and myocardial oxygen demand, especially if the patient is stable.

Use of Statin Therapy in treating Acute Coronary Syndrome

Statins, such as atorvastatin or rosuvastatin, are initiated or continued to lower cholesterol levels and reduce the risk of future events.

Effectiveness of ACE Inhibitors or ARBs in treating Acute Coronary Syndrome

Angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs) may be prescribed in the subacute phase to improve cardiac function and reduce the risk of complications.

role-of-surgical-care-in-treating-acute-coronary-syndrome

STEMI: Urgent revascularization is the goal. This can be achieved through primary percutaneous coronary intervention (PCI) or thrombolytic therapy. PCI is preferred if available within a timely window.

NSTEMI: An early invasive strategy, involving coronary angiography and PCI if indicated, is commonly employed.

role-of-management-in-treating-acute-coronary-syndrome

Initial (Pre-Hospital) Phase:

Aspirin to prevent further clotting.

Oxygen if necessary (for low saturation or distress).

Nitroglycerin to relieve chest pain (if no contraindications).

Pain control with morphine.

Anticoagulation (e.g., heparin) to prevent further clot formation.

Hospital (Early) Phase:

Monitoring: Continuous ECG and vital sign monitoring.

Reperfusion therapy for STEMI (PCI or thrombolysis).

Antiplatelet therapy (Aspirin + P2Y12 inhibitors).

Anticoagulation (heparin).
Risk stratification to guide further intervention.

Intermediate Phase (Post-Reperfusion):

Post-PCI care (monitor for complications).

Beta-blockers, ACE inhibitors/ARBs, and statins.

Continued antiplatelet therapy (Dual Antiplatelet Therapy).

Late Phase (Discharge & Long-Term):
Secondary prevention: Lifestyle changes, medications, and patient education.

Cardiac rehabilitation to improve recovery and reduce future risk.

Follow-up for ongoing care and management of risk factors.

Medication

 

ticagrelor

Loading dose (following ACS event): 180 mg orally, single dose
The maintenance dose (for 1st 12 months after diagnosis): 90 mg orally two times
The maintenance dose (after 12 months from diagnosis): 60 mg orally two times
Also, continue with aspirin 75-100 mg



tirofiban 

25

mcg/kg

Solution

Intravenous (IV)

5

minutes



eptifibatide 

180

mcg/kg

Solution

Intravenous (IV)

1 - 2

minutes

Later, 2 mcg/kg/min intravenously for 72 hours



prasugrel 

Initial dose
:

60

mg

Tablet

Orally 

once a day


Maintenance dose: 10mg/day orally combined with 81-325mg/day aspirin



clopidogrel 

Non-ST-Elevation Myocardial Infarction (NSTEMI)
Loading dose:

300

mg

Tablet

Orally 

every day


Maintenance dose: 75 mg orally daily

ST-Elevation Myocardial Infarction (STEMI)
Loading dose: 300 mg orally daily
Maintenance dose: 75 mg orally daily with/without thrombolytics



heparin 

PCI
Without the GPIIb or IIIa inhibitor: 70 to 100 unit/kg Intravenous bolus initially
With GPIIb or IIIa inhibitor: 50 to 70 units/kg Intravenous bolus initially
STEMI
Patient who are on fibrinolytics: IV bolus of 60 units/kg (maximum: 4000 units), following 12 units/kg in hour as continuous IV infusion (max 1000 units/hr)
The dose must be adjusted to keep the aPTT between 50 to 70 seconds
NSTEMI/Unstable Angina
6 to 70 units/kg intravenous bolus initially (maximum: 5000 units), following 12-15 units/kg in hour intravenous infusion initially (maximum: 1000 units/hr)
The dose must be adjusted to keep the aPTT between 50 to 70 secs
Dosing considerations
There are several concentrations available; extreme caution is necessary to prevent a medication error



nadroparin 

Administer initial dose of 86 anti-Xa units/kg intravenously once bolus and the maximum dose not more than 9500 anti-Xa units
Fixed dosing:
<50 kg: dose of 3800 anti-Xa units once intravenous bolus
≥100 kg: dose of 9500 anti-Xa units once intravenous bolus
Administer maintenance dose of 86 anti-Xa units/kg subcutaneously each 12 hours and the maximum total daily dose not more than 19000 anti-Xa units
Fixed dosing:
<50 kg: dose of 3800 anti-Xa units subcutaneously each 12 hours
≥100 kg: dose of 9500 anti-Xa units subcutaneously each 12 hours



 
 

prasugrel 

Acute Coronary Syndrome
<75 years:
Loading dose: 60mg orally
Maintenance dose: 10mg/day orally combined with 81-325mg/day aspirin
>75 years:
Not recommended due to intracranial bleeding



Media Gallary

Content loading

Latest Posts

Acute Coronary Syndrome

Updated : April 7, 2025

Mail Whatsapp PDF Image



Acute coronary syndrome (ACS) refers to a range of conditions caused by a sudden reduction or blockage of blood flow to the heart muscle, often due to the rupture of a plaque in the coronary arteries. ACS is a medical emergency and includes three main types: unstable angina, non-ST segment elevation myocardial infarction (NSTEMI), and ST-segment elevation myocardial infarction (STEMI). Unstable angina involves a partial blockage and causes chest pain or discomfort, serving as a warning sign of a potential heart attack. NSTEMI is less severe, with partial or temporary blockage leading to some heart muscle damage. STEMI is the most severe, involving a complete blockage and causing significant heart muscle damage, requiring immediate medical attention.

Acute coronary syndrome (ACS): Leading cause of morbidity and mortality worldwide, affecting millions annually.

Incidence: Varies by region, age, and other factors; common cardiovascular emergency.

Prevalence: Influenced by risk factors such as hypertension, diabetes, smoking, and obesity.

Gender differences: Historically more common in men, but the gender gap is narrowing; significant cause of death and morbidity in both genders.

Seasonal pattern: Increased incidence during winter; cold weather and other factors may contribute to this variation.

Acute coronary syndrome (ACS): Involves a reduction in blood flow to a segment of the heart muscle.

Primary cause: Typically, due to the rupture of a plaque within a coronary artery.

Thrombus formation: The rupture leads to the formation of a blood clot (thrombus).

Other causes: Can also be attributed to vasospasm, with or without underlying atherosclerotic conditions.

Initial effect: Reduced blood flow results in ischemia (insufficient blood supply).

Subsequent effect: Ischemia leads to infarction (tissue damage) of the affected heart region.

Acute Coronary Syndrome (ACS): Manifestation of coronary heart disease.

Primary cause: Disruption of plaques within the coronary arteries.

Prevalent risk factors:
Smoking
Diabetes
High blood pressure
Elevated lipid levels
Sedentary lifestyle
Familial obesity
Poor dietary habits
Cocaine abuse: Can induce vasospasms, increasing risk.

Family history: Early myocardial infarction (before age 55) is a significant risk factor.

Acute coronary syndrome (ACS) often affects individuals with risk factors like coronary artery disease (CHD), smoking, hypertension, diabetes, hyperlipidemia, and a family history of heart disease. Patients may have a history of angina or heart attacks.

Symptoms include new or worsening chest pain (crushing, squeezing, or pressure-like), shortness of breath, nausea, vomiting, and sweating.

ACS typically has a sudden onset and can present with persistent or intermittent symptoms, including rest and exertional angina. The exact symptoms can vary among individuals.

Age group
Middle-Aged Adults (40-60 years):
This is a more common age range for ACS, as risk factors such as hypertension, high cholesterol, smoking, and diabetes tend to accumulate during this period.
Men typically have a higher incidence of ACS in this age group, although the gap is narrowing as cardiovascular risk factors in women rise.

Older Adults (Over 60 years):
ACS becomes much more common in this age group, with the risk increasing as people age due to the natural progression of coronary artery disease (CAD), which often goes undiagnosed for many years.

Patients with ACS often exhibit general distress and diaphoresis. Heart sounds are usually normal, but in some cases, healthcare providers may detect additional sounds like gallops or murmurs. Lung examination typically reveals no abnormalities, though crackles may be heard in some cases, suggesting associated congestive heart failure. Bilateral leg swelling or edema may be present, which can be indicative of CHF. Evaluations of other body systems typically yield results within normal limits unless there are concurrent medical conditions. When abdominal tenderness is noted upon palpation, healthcare providers should consider the possibility of other conditions, such as pancreatitis or gastritis. The presence of unequal pulses should raise suspicion of aortic dissection, warranting further evaluation. If unilateral leg swelling is detected, a thorough work-up for pulmonary emboli is advisable.

Hypertension (High Blood Pressure)
Diabetes Mellitus
Dyslipidemia (Abnormal Cholesterol Levels)
Peripheral Artery Disease (PAD)

ST-Elevation Myocardial Infarction (STEMI):

Most acute: Sudden, severe chest pain, often crushing in nature, with rapid deterioration. Immediate intervention (e.g., PCI or thrombolysis) is critical to minimize heart damage.

Non-ST-Elevation Myocardial Infarction (NSTEMI):
Moderately acute: Chest pain, shortness of breath, and discomfort may be less intense but still severe. Requires urgent care with antiplatelet therapy and potential angiography.

Unstable Angina:
Less acute but still urgent: Chest pain at rest or with minimal exertion, with no significant muscle damage (no troponin elevation). Needs close monitoring and possible early revascularization.

Acute pericarditis
Aortic stenosis
Anxiety disorders
Asthma
Dilated cardiomyopathy
Esophagitis
Myocardial infarction

Immediate medical assessment and diagnosis:
Electrocardiography (ECG) and cardiac biomarker tests

Initial treatments:
Oxygen therapy
Pain relief with nitroglycerin and opioids
Administration of antiplatelet and anticoagulant medications

Revascularization procedures (Depending on type of ACS – STEMI or NSTEMI):
Primary percutaneous coronary intervention (PCI)
Thrombolytic therapy

Long-term management:
Beta-blockers
ACE inhibitors or ARBs
Statins
Lifestyle modifications
Cardiac rehabilitation

Psychological support:
Addressing the emotional impact of ACS
Ensuring comprehensive care and better patient outcomes

STEMI: Urgent revascularization is the goal. This can be achieved through primary percutaneous coronary intervention (PCI) or thrombolytic therapy. PCI is preferred if available within a timely window.

NSTEMI: An early invasive strategy, involving coronary angiography and PCI if indicated, is commonly employed.

Cardiology, General

Encourage patients to make lifestyle changes, such as quitting smoking, adopting a heart-healthy diet, losing weight if necessary, and managing underlying risk factors like hypertension and diabetes.

Cardiology, General

Cardiology
Aspirin is administered promptly to inhibit platelet aggregation. Additional antiplatelet agents like P2Y12 inhibitors (e.g., clopidogrel, ticagrelor, or prasugrel) are initiated. Anticoagulants such as heparin or enoxaparin are given to prevent further clot formation.

Cardiology, General

Beta-blockers, like metoprolol, may be administered to reduce heart rate, blood pressure, and myocardial oxygen demand, especially if the patient is stable.

Cardiology, General

Statins, such as atorvastatin or rosuvastatin, are initiated or continued to lower cholesterol levels and reduce the risk of future events.

Cardiology, General

Angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs) may be prescribed in the subacute phase to improve cardiac function and reduce the risk of complications.

Cardiology, General

STEMI: Urgent revascularization is the goal. This can be achieved through primary percutaneous coronary intervention (PCI) or thrombolytic therapy. PCI is preferred if available within a timely window.

NSTEMI: An early invasive strategy, involving coronary angiography and PCI if indicated, is commonly employed.

Cardiology, General

Initial (Pre-Hospital) Phase:

Aspirin to prevent further clotting.

Oxygen if necessary (for low saturation or distress).

Nitroglycerin to relieve chest pain (if no contraindications).

Pain control with morphine.

Anticoagulation (e.g., heparin) to prevent further clot formation.

Hospital (Early) Phase:

Monitoring: Continuous ECG and vital sign monitoring.

Reperfusion therapy for STEMI (PCI or thrombolysis).

Antiplatelet therapy (Aspirin + P2Y12 inhibitors).

Anticoagulation (heparin).
Risk stratification to guide further intervention.

Intermediate Phase (Post-Reperfusion):

Post-PCI care (monitor for complications).

Beta-blockers, ACE inhibitors/ARBs, and statins.

Continued antiplatelet therapy (Dual Antiplatelet Therapy).

Late Phase (Discharge & Long-Term):
Secondary prevention: Lifestyle changes, medications, and patient education.

Cardiac rehabilitation to improve recovery and reduce future risk.

Follow-up for ongoing care and management of risk factors.

Free CME credits

Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.

Digital Certificate PDF

On course completion, you will receive a full-sized presentation quality digital certificate.

medtigo Simulation

A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.

medtigo Points

medtigo points is our unique point redemption system created to award users for interacting on our site. These points can be redeemed for special discounts on the medtigo marketplace as well as towards the membership cost itself.
 
  • Registration with medtigo = 10 points
  • 1 visit to medtigo’s website = 1 point
  • Interacting with medtigo posts (through comments/clinical cases etc.) = 5 points
  • Attempting a game = 1 point
  • Community Forum post/reply = 5 points

    *Redemption of points can occur only through the medtigo marketplace, courses, or simulation system. Money will not be credited to your bank account. 10 points = $1.

All Your Certificates in One Place

When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.

Our Certificate Courses